SV Life Sciences has closed its fourth fund with $572 million in capital commitments. The firm focuses on venture capital opportunities in the life sciences space, and had originally targeted $500 million. www.svlsla.com
SV Life Sciences has closed its fourth fund with $572 million in capital commitments. The firm focuses on venture capital opportunities in the life sciences space, and had originally targeted $500 million. www.svlsla.com
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.